Overview
A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders.
Indication
For use as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called "histaminic cephalalgia".
Associated Conditions
- Cluster Headache
- Migraine
- Uterine Atony
- Vascular Headaches
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Cintex Services, LLC | 24470-917 | ORAL | 1 mg in 1 1 | 12/21/2021 | |
| Rosedale Therapeutics | 10802-1202 | SUBLINGUAL | 2 mg in 1 1 | 9/8/2012 | |
| Cosette Pharmaceuticals, Inc. | 0713-0166 | RECTAL | 2 mg in 1 1 | 11/29/2022 | |
| TerSera Therapeutics, LLC | 70720-120 | ORAL | 2 mg in 1 1 | 12/1/2016 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| CAFFOX TABLET | SIN11746P | TABLET | 1 mg | 12/26/2001 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| WIGRAINE TAB | organon canada ltd ltee | 00489220 | Tablet - Oral | 1 MG / TAB | 12/31/1980 |
| MEGRAL TABS | glaxo wellcome inc. | 00068586 | Tablet - Oral | 2 MG / TAB | 12/31/1989 |
| CAFERGOT SUP | novartis pharmaceuticals canada inc | 00782920 | Suppository - Rectal | 2 MG / SUP | 12/31/1990 |
| ERGODRYL CAP | erfa canada 2012 inc | 00156086 | Capsule - Oral | 1 MG | 12/31/1964 |
| BELLERGAL SPACETABS | paladin pharma inc. | 00176141 | Tablet (Extended-Release) - Oral | 0.6 MG | 1/1/1959 |
| ERGOMAR SLT 2MG | aventis pharma inc | 00328952 | Tablet - Sublingual | 2 MG / SLT | 12/31/1975 |
| GRAVERGOL CAPSULES | can-med pharma inc. | 00116858 | Capsule - Oral | 1 MG | 12/31/1957 |
| CAFERGOT TAB | novartis pharmaceuticals canada inc | 00176095 | Tablet - Oral | 1 MG | 12/31/1951 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.